| Predicting exacerbation of renal function by DNA methylation clock and DNA damage of urinary shedding cells: a pilot study A Hishikawa, ES Nishimura, N Yoshimoto, R Nakamichi, EY Hama, W Ito, ... Scientific reports 14 (1), 11530, 2024 | | 2024 |
| Efficacy of sucrose and povidone–iodine mixtures in peritoneal dialysis catheter exit-site care T Nakayama, K Morimoto, K Uchiyama, N Washida, E Kusahana, ... BMC nephrology 25 (1), 151, 2024 | | 2024 |
| Combining hemodialysis with peritoneal dialysis improves cognitive function: a three-case report T Maruki, T Nakayama, K Morimoto, K Uchiyama, N Washida, R Mitsuno, ... CEN case reports, 1-5, 2024 | | 2024 |
| Podocyte Ercc1 is indispensable for glomerular integrity EY Hama, R Nakamichi, A Hishikawa, M Kihara, T Abe, N Yoshimoto, ... Biochemical and Biophysical Research Communications, 149713, 2024 | 1 | 2024 |
| DNA Double-Strand Breaks in Proximal Tubular Epithelial Cells Induce a Systemic Lipodystrophy-Like Phenotype: FR-PO1030 ES Nishimura, A Hishikawa, R Nakamichi, EY Hama, K Hayashi Journal of the American Society of Nephrology 34 (11S), 691, 2023 | | 2023 |
| DNA-damaged podocyte-CD8 T cell crosstalk exacerbates kidney injury by altering DNA methylation R Nakamichi, A Hishikawa, S Chikuma, A Yoshimura, T Sasaki, ... Cell reports 42 (4), 2023 | 5 | 2023 |
| Significance of podocyte DNA damage and glomerular DNA methylation in CKD patients with proteinuria N Yoshimoto, K Hayashi, A Hishikawa, A Hashiguchi, R Nakamichi, ... Hypertension Research 46 (4), 1000-1008, 2023 | 9 | 2023 |
| Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection T Nakayama, T Azegami, M Kiso, M Imai, R Uraki, K Hayashi, ... Scientific reports 13 (1), 3103, 2023 | 1 | 2023 |
| PS-B04-12: DEVELOPMENT OF VACCINE AGAINST CONNECTIVE TISSUE GROWTH FACTOR TO PREVENT THE PROGRESSION OF RENAL FIBROSIS T Nakayama, T Azegami, K Hayashi, A Hishikawa, N Yoshimoto, ... Journal of Hypertension 41 (Suppl 1), e362, 2023 | | 2023 |
| S-38-4: ASSOCIATION BETWEEN DNA METHYLATION AGE OR DNA DAMAGE IN URINARY SHEDDING CELLS AND EARLY CKD A Hishikawa, K Hayashi, E Sugita, N Yoshimoto, R Nakamichi, E Yoshida, ... Journal of Hypertension 41 (Suppl 1), e85-e86, 2023 | | 2023 |
| PS-C26-12: SIGNIFICANCE OF PODOCYTE DNA DAMAGE AND GLOMERULAR DNA METHYLATION IN CKD WITH PROTEINURIA N Yoshimoto, K Hayashi, A Hishikawa, R Nakamichi, E Sugita, E Yoshida, ... Journal of Hypertension 41 (Suppl 1), e417, 2023 | | 2023 |
| S-38-7: CONTINUOUS NON-MUTAGENIC DNA DAMAGE IN PODOCYTES ACTIVATES PATHOGENIC MEMORY T CELLS THROUGH ALTERED DNA METHYLATION R Nakamichi, K Hayashi, A Hishikawa, S Chikuma, N Yoshimoto, E Sugita, ... Journal of Hypertension 41 (Suppl 1), e86-e87, 2023 | | 2023 |
| Continuous Non-Mutagenic DNA Damage in Podocytes Activates Pathogenic Memory T Cells Through Altered DNA Methylation: SA-OR23 R Nakamichi, K Hayashi, A Hishikawa, H Itoh Journal of the American Society of Nephrology 33 (11S), 40, 2022 | | 2022 |
| Vaccination against connective tissue growth factor attenuates the development of renal fibrosis T Nakayama, T Azegami, K Hayashi, A Hishikawa, N Yoshimoto, ... Scientific reports 12 (1), 10933, 2022 | 1 | 2022 |
| DNA repair factor KAT5 prevents ischemic acute kidney injury through glomerular filtration regulation A Hishikawa, K Hayashi, A Kubo, K Miyashita, A Hashiguchi, K Kinouchi, ... Iscience 24 (12), 2021 | 5 | 2021 |
| Home‐based aerobic exercise and resistance training for severe chronic kidney disease: a randomized controlled trial K Uchiyama, K Adachi, K Muraoka, T Nakayama, T Oshida, M Yasuda, ... Journal of cachexia, sarcopenia and muscle 12 (6), 1789-1802, 2021 | 39 | 2021 |
| Continuous Non-Mutagenic DNA Damage in Podocytes Activates Inflammatory Response and May Accelerate Kidney Aging: PO1708 R Nakamichi, A Hishikawa, K Hayashi, H Itoh Journal of the American Society of Nephrology 32 (10S), 531, 2021 | | 2021 |
| Epigenetic alterations in podocytes in diabetic nephropathy E Sugita, K Hayashi, A Hishikawa, H Itoh Frontiers in Pharmacology 12, 759299, 2021 | 19 | 2021 |
| Vaccination against receptor for advanced glycation end products attenuates the progression of diabetic kidney disease T Azegami, T Nakayama, K Hayashi, A Hishikawa, N Yoshimoto, ... Diabetes 70 (9), 2147-2158, 2021 | 18 | 2021 |
| ACTIVE IMMUNOTHERAPY AGAINST RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS ATTENUATES THE PROGRESSION OF DIABETIC KIDNEY DISEASE T Azegami, K Hayashi, A Hishikawa, N Yoshimoto, T Nakayama, H Itoh Journal of Hypertension 39, e303, 2021 | | 2021 |
